| Dec, 8 | New Executive Committee Member more.. |
| Nov, 17 | Tasmar® label change in the US - Suspension in the European Union more.. |
| Oct, 29 | The European Commission approves sale of De Puy more.. |
| Oct, 20 | Management Change in the Pharmaceuticals Division more.. |
| Oct, 14 | Roche to invest in new Biotin Plant in Germany more.. |
| Oct, 12 | Roche continues to post strong sales growth in third quarter more.. |
| Oct, 6 | Roche supports the formation of the Sight and Life Research Institute at the Johns Hopkins School of Public Health more.. |
| Oct, 5 | Roche to sell four pharmaceutical products to ICN more.. |
| Nov, 24 | New oral flu drug significantly cuts suffering and reduces secondary complications more.. |
| Nov, 10 | Roche introduces four new diabetes monitoring products more.. |
| Aug, 27 | Fortovase® receives approval in the European Union more.. |
| Aug, 18 | New head of diagnostics division more.. |
| Aug, 18 | EU approval for CellCept® in heart transplantation more.. |
| Aug, 17 | Further Increase for the First Half of 1998 more.. |
| Jul, 31 | Xenical® receives approval in the European Union more.. |
| Jul, 21 | Roche sells its majority stake in DePuy more.. |
| Jul, 17 | Roche's anti-obesity drug Xenical® lowers cardiovascular risks more.. |
| Jul, 15 | Roche sets up a Transplantation Research Foundation more.. |
| Jul, 13 | Roche grants Bayer worldwide access to PCR more.. |
| Jul, 10 | Roche continues to post strong sales growth through second quarter more.. |
| Jul, 6 | Roche and Genentech sign Licensing Agreement for Herceptin® more.. |
| Jun, 28 | Roche presents significant progress in the treatment schedule for HIV-patients and an important new HIV-research program at the 12th World AIDS Conference more.. |
| Jun, 17 | Roche strengthens oncology portfolio with novel compound for prostate cancer more.. |
| Jun, 8 | Roche announces voluntary withdrawal of Posicor more.. |
| Jun, 8 | Roche pleased at referendum result more.. |
| Jun, 3 | MabThera® receives marketing authorization in the European Union more.. |
| May, 14 | Roche agrees on Global Cooperation with TOA Medical Electronics more.. |
| May, 13 | FDA grants approvability status to Roche's Xenical® (Orlistat) more.. |
| May, 5 | Roche 1998 Annual General Meeting more.. |
| May, 1 | FDA grants accelerated approval for Xeloda TM: the first oral tumoractivated drug to treat metastatic breast cancer more.. |
| Apr, 23 | Roche to invest in new Vitamin B2 Plant in Germany more.. |
| Apr, 7 | Roche Group's sales surge in first quarter more.. |
| Mar, 24 | Another marked rise in consolidated net income before special charges more.. |
| Mar, 16 | Zenapax®, first genetically engineered drug to prevent organ rejection, launched in Switzerland more.. |
| Mar, 13 | FDA panel ties 5-5 on approval of orlistat for obesity more.. |
| Mar, 11 | Sun protection and skin cancer - results of a new study more.. |
| Mar, 6 | Corange acquisition formally closed more.. |
| Mar, 3 | Roche expanding pharma research in Germany to meet new challenges more.. |
| Feb, 25 | US regulators approve Roche's proposed acquisition of Corange more.. |
| Feb, 13 | US approval for CellCept® in heart transplantation more.. |
| Feb, 4 | EU Commission authorises acquisition of Corange Ltd by Roche more.. |
| Feb, 2 | Roche and DeCode Genetics Inc. of Iceland collaborate in genetic disease research more.. |
| Feb, 2 | Roche invests in Poland: Feed premix facility more.. |
| Jan, 30 | Tasmar, first in a new class of Parkinson's Drugs, receives Clearance in the United States more.. |
| Jan, 26 | Roche making new investments in its vitamin C factory in Scotland more.. |
| Jan, 22 | European Approval for Viracept, a new anti-HIV drug for both adults and children more.. |
| Jan, 16 | Marked sales growth for Roche Group in 1997 more.. |
| Jan, 12 | Roche and Progenics to collaborate in HIV research to identify novel HIV therapeutics more.. |
print this page